Last checked at 10 May 2021 14:08
FORM 8.3 Amendment to purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. |
Company dealt in | WILLIS TOWERS WATSON PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) | ORD |
Date of dealing | 06 May 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,692,871 | 1.31% | 168,438 | 0.13% | ||
(2) | Derivatives (other than options): | ||||
72,359 | 0.06% | 0 | 0.00% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
(4) | TOTAL: | ||||
1,770,699 | 1.37% | 174,538 | 0.14% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 2 | 265.7000 USD |
| Purchase | 3 | 266.5600 USD |
| Purchase | 3 | 265.0900 USD |
| Purchase | 6 | 266.3925 USD |
| Purchase | 22 | 265.1500 USD |
| Purchase | 38 | 265.2300 USD |
| Purchase | 50 | 264.7900 USD |
| Purchase | 71 | 265.4200 USD |
| Purchase | 180 | 264.8500 USD |
| Purchase | 200 | 264.8550 USD |
| Purchase | 215 | 264.7976 USD |
| Purchase | 231 | 265.6446 USD |
| Purchase | 257 | 264.7527 USD |
| Purchase | 307 | 265.3980 USD |
| Purchase | 325 | 265.2696 USD |
| Purchase | 500 | 265.0770 USD |
| Purchase | 606 | 265.5836 USD |
| Purchase | 760 | 266.3672 USD |
| Purchase | 784 | 264.9206 USD |
| Purchase | 2,014 | 265.0757 USD |
| Purchase | 2,218 | 266.0969 USD |
| Purchase | 2,358 | 265.0513 USD |
| Purchase | 2,417 | 265.3484 USD |
| Purchase | 2,477 | 265.4268 USD |
| Purchase | 4,075 | 266.5096 USD |
| Purchase | 5,651 | 265.8002 USD |
| Purchase | 6,479 | 265.3301 USD |
| Purchase | 6,743 | 265.9572 USD |
| Purchase | 11,918 | 266.2825 USD |
| Purchase | 20,328 | 266.5100 USD |
| Sale | 1 | 266.4300 USD |
| Sale | 1 | 266.5800 USD |
| Sale | 2 | 265.7000 USD |
| Sale | 2 | 266.6600 USD |
| Sale | 3 | 266.6400 USD |
| Sale | 11 | 265.1800 USD |
| Sale | 11 | 265.1500 USD |
| Sale | 12 | 264.1300 USD |
| Sale | 24 | 266.9025 USD |
| Sale | 200 | 267.3150 USD |
| Sale | 200 | 266.6350 USD |
| Sale | 211 | 266.5370 USD |
| Sale | 400 | 265.7825 USD |
| Sale | 591 | 266.3246 USD |
| Sale | 600 | 266.3083 USD |
| Sale | 627 | 265.8807 USD |
| Sale | 692 | 265.7564 USD |
| Sale | 760 | 266.3672 USD |
| Sale | 1,356 | 266.4581 USD |
| Sale | 2,339 | 265.8763 USD |
| Sale | 2,563 | 265.3384 USD |
| Sale | 3,355 | 266.5079 USD |
| Sale | 3,989 | 265.7158 USD |
| Sale | 4,075 | 266.5096 USD |
| Sale | 5,855 | 264.9896 USD |
| Sale | 9,655 | 265.3435 USD |
| Sale | 12,834 | 266.0398 USD |
| Sale | 20,001 | 266.5100 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure | 10 May 2021 |
Contact name | Large Holdings Regulatory Operations |
Telephone number | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection (Note 10) |
|
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
| Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
| Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
| Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210510005523/en/
Copyright Business Wire 2021